Condition: Coronary Artery Disease(CAD) · Sponsor: Sinotau Pharmaceutical Group
The primary objective of this study is to evaluate the effectiveness of visual reading in XTR004 PET myocardial perfusion imaging (MPI) for detecting restrictive stenosis, using quantitative coronary angiography (QCA) and fractional flow reserve (FFR) as reference standards in patients with suspected or known coronary artery disease.
This description comes directly from the study's public registry record.
LING YUAN · 010-80716990 · ling.yuan@sinotau.com
Always discuss trial participation with your own doctor first.
| Beijing Anzhen Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing Tongren Hospital | Beijing, China | Recruiting |
| Peking Union Medical College Hospital | Beijing, China | Recruiting |
| The First People's Hospital of Foshan | Foshan, China | Recruiting |
| TEDA International Cardiovascular Hospital | Tianjin, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07439133